Intrinsic Value

The intrinsic value of Sequana Medical NV (2SE) under the Base Case is 0.853 EUR per share. Compared with the current market price of 0.512 EUR, the stock appears Undervalued by 40% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

2SE Intrinsic Value
€0.853
Undervaluation 40%
Intrinsic Value
Price €0.512

2SE is cheaper than usual. It was this cheap or cheaper on just 11% of days in the past 5 years.

Alert me when 2SE is below its intrinsic value
Today €0.512 · 0.0% below the current price
Alternatives to 2SE

Fundamental Analysis

What Sequana Medical Does

Health Care

Sequana Medical makes implantable medical devices that help remove unwanted fluid from the body. Its best-known product is the alfapump, a small pump system that moves excess abdominal fluid out of the body in patients with severe liver disease and related fluid buildup. The company is also developing other treatments for fluid overload, including therapies aimed at heart failure patients.

Headquarters
Belgium BE
Employees
48
IPO date
Feb 11, 2019
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue 2SE Research

Decided on Sequana Medical? Get an email when 2SE reaches the price you’d buy at. Free with an account.

Other Sequana Medical listings

What is the Intrinsic Value of one 2SE stock?

The intrinsic value for Sequana Medical NV (2SE) under the Base Case is 0.853 EUR.

Is 2SE stock undervalued or overvalued?

Compared with the current market price of 0.512 EUR, the stock appears Undervalued by 40% .

How reliable are our estimates? See how past valuations played out
Back to Top